Can a daily pill help older adults regain strength?

NCT ID NCT07072195

Recruiting now Disease control Sponsor: Animuscure Inc. Source: ClinicalTrials.gov ↗

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This clinical trial is testing whether an experimental oral drug called AMC6156 can improve physical function and safety in older adults with sarcopenia, a condition marked by loss of muscle mass and strength. Participants will take either AMC6156 or a placebo daily for 12 weeks, and their movement, strength, and safety will be monitored through tests and checkups. The study aims to see if the drug can help improve mobility and quality of life in this population.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AMC6156
What this could lead to: If successful, this could lead to a new oral treatment to help older adults with sarcopenia regain strength and mobility, improving independence and quality of life.
What could go wrong: This is an early-stage trial with a small number of participants, so results may not be conclusive. The drug may not prove more effective than placebo, and there could be side effects not yet known.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARCOPENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SARCOPENIA SARCOPENIA IN ELDERLY

Contacts and locations

Locations

Ajou University Hospital
RECRUITING

Suwon, Gyeonggi-do, 16499, South Korea
CHA Bundang Medical Center
RECRUITING

Seongnam-si, Gyeonggi-do, 13496, South Korea
Seoul National University Bundang Hospital
RECRUITING

Seongnam-si, Gyeonggi-do, 13620, South Korea
Seoul National University Hospital
RECRUITING

Seoul, Seoul, 03080, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.